Skip to content
sellModerate cluster of 4

Rami Elghandour sold $2.2M of ACLX

SEE REMARKS at Arcellx, Inc.. 28,633 shares at an average of $78.40, traded Jan 3, 2025, filed Jan 6, 2025.

Warning score
45
Value
$2.2M
28,633 shares
Holdings after
149,176
-16% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $2.2M at market
    +25
  • Share of holdings sold
    Sold 16% of holdings
    +5
  • Cluster
    4 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001415889-25-000948, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jan 2, 2025MOption exercise
Common Stock
+55,459$0.00$0124,712Jan 6, 2025
Jan 3, 2025MOption exercise
Common Stock
+53,097$0.00$0177,809Jan 6, 2025
Jan 3, 2025SOpen-market sale
Common Stock
-14,857$79.55$1.2M162,952Jan 6, 2025
Jan 6, 2025SOpen-market sale
Common Stock
-13,776$77.17$1.1M149,176Jan 6, 2025
Jan 2, 2025MOption exercise
Restricted Stock Unitderivative
-55,459$0.00$0110,918Jan 6, 2025
Jan 3, 2025MOption exercise
Restricted Stock Unitderivative
-53,097$0.00$053,098Jan 6, 2025
Jan 6, 2025AGrant or award
Restricted Stock Unitderivative
+223,964$0.00$0223,964Jan 6, 2025

Related signals

Other insiders at Arcellx, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
40Moderate
ACLXsell10b5-1
Arcellx, Inc.
Christopher Heery
CHIEF MEDICAL OFFICER
$1.7M
21,034 shares
-97%
0Weak
ACLXsell10b5-1
Arcellx, Inc.
Christopher Heery
CHIEF MEDICAL OFFICER
$5,852
73 shares
-0%
30Weak
ACLXsell10b5-1
Arcellx, Inc.
Christopher Heery
CHIEF MEDICAL OFFICER
$993k
12,396 shares
-36%
9Weak
ACLXsell10b5-1
Arcellx, Inc.
Christopher Heery
CHIEF MEDICAL OFFICER
$291k
3,643 shares
-10%
18Weak
ACLXsell 210b5-1
Arcellx, Inc.
Kavita Patel
director
$101k
1,500 shares
-100%
47Moderate
ACLXsell 2
Arcellx, Inc.
Michelle Gilson
CHIEF FINANCIAL OFFICER
$785k
12,235 shares
-38%
17Weak
ACLXsell 210b5-1
Arcellx, Inc.
Kavita Patel
director
$88k
1,500 shares
-100%
10Weak
ACLXsell10b5-1
Arcellx, Inc.
Kavita Patel
director
$96k
1,500 shares
-100%
9Weak
ACLXsell10b5-1
Arcellx, Inc.
Kavita Patel
director
$86k
1,500 shares
-100%
10Weak
ACLXsell10b5-1
Arcellx, Inc.
Kavita Patel
director
$107k
1,500 shares
-100%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Rami Elghandour sold $2.2M of ACLX | InsiderTell